The identification of deleterious mutations in the breast cancer susceptibility genes BRCA1 and BRCA2 has important implications for mutation carriers in general, because they are the principal cause of Hereditary Breast and/or Ovarian Cancer Syndrome (Miki et al., 1994; Wooster et al., 1995). This evidence concerns the gene BRCA1 and breast carcinoma.